Added: Shaelyn Gossard - Date: 26.06.2021 19:37 - Views: 23958 - Clicks: 6101
Main outcome measures: Co-primary endpoints were changed from baseline to study end in of satisfying sexual events SSE and sexual desire score, measured daily using an eDiary. No group showed a ificant increase in eDiary desire score vs.
More women receiving flibanserin 50 mg twice daily and mg once daily considered their HSDD to have improved than women receiving placebo The most frequently reported adverse events in women receiving flibanserin were somnolence Conclusion: In premenopausal women with HSDD, flibanserin mg once daily was well tolerated and associated with statistically ificant improvements in SSE, sexual desire FSFI desire domain score but not eDiary desire scoresexual function, and decrease in sexual distress vs.
Trial registration: ClinicalTrials. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. Search: Search. Advanced Clipboard. Display options Display options. Create file Cancel. citation Subject: 1 selected item: - PubMed. Format: Summary Summary text Abstract Abstract text.
MeSH and other data. Send Cancel. Add to Collections Create a new collection Add to an existing collection. Name your collection: Name must be less than characters.
Choose a collection: Unable to load your collection due to an error Please try again. Add Cancel. Add to My Bibliography My Bibliography. Unable to load your delegates due to an error Please try again. Your saved search Name of saved search:.
Search terms:. Test search terms. Would you like updates of new search ? : change. Frequency: Monthly Weekly Daily. Which day? Send at most: 1 item 5 items 10 items 20 items 50 items items items. Send even when there aren't any new. Optional text in :. Save Cancel. Create a file for external citation management software Create file Cancel.
of items displayed: 5 10 15 20 50 Create RSS Cancel. RSS Link Copy. Full text links Cite Display options Display options. Derogatis LR, et al. J Sex Med. Epub Jan Katz M, et al. Epub May Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder HSDD : from a randomized withdrawal trial. Goldfischer ER, et al. Epub Sep Gao Z, et al. PMID: Review. Jaspers L, et al. See all similar articles.
Cited by 32 articles Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians. Cocchetti C, et al. Int J Impot Res. Online ahead of print. International Union of Basic and Clinical Pharmacology. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.
Barnes NM, et al. Pharmacol Rev. Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder. Revicki DA, et al. J Patient Rep Outcomes. Simon JA, et al.
Obstet Gynecol. Millheiser L, et al. Sex Med. See all "Cited by" articles. Randomized Controlled Trial Actions. Research Support, Non-U. Gov't Actions. MeSH terms Adult Actions. Female Actions. Humans Actions. Premenopause Actions. Treatment Outcome Actions. Substances Benzimidazoles Actions. Serotonin Agents Actions. Associated data ClinicalTrials. Full text links [x] Elsevier Science. Copy Download.Women want sex Daisy
email: [email protected] - phone:(952) 879-9601 x 2445
Follow the Author